| Application no. and date | 09011389.5 (espacenet) (Federated) (European Patent Register), 20030313 | | Patent/reg. no. and date | DK/EP 2130537, 20121114 | | Publication date | 20091209 | | Priority no. and date | US 364007 P, 20020313 | | EP pub. no. and date |
EP 2130537 20091209 | | Effective date | | | Applicant/owner | Array BioPharma Inc., 3200 Walnut Street
Boulder, CO 80301, US,
AstraZeneca AB, Västra Mälarehamnen 9
151 85 Södertälje, SE | | Applicant ref. no. | 63481 | | Inventor | Wallace, Eli, M., P.O. Box 1727
Lyons
CO 80540, US,
Lyssikatos, Joseph, P., Array Biopharma Inc.
3200 Walnut Street
Boulder
CO 80301, US,
Hurley, Brian, T., Arry Biopharma, Inc.
3200 Walnut Street
Boulder, Colorado 80301
, US,
Marlow, Allison, L., Array Biopharma, Inc.
3200 Walnut Street
Boulder, Colorado 80301
, US | | Representative | Larsen & Birkeholm A/S Skandinavisk Patentbureau, Banegårdspladsen 1, 1570 København V | | Opponent | | | IPC Class | A61K 31/4184 (2006.01) , A61P 35/00 (2006.01) , C07D 235/04 (2006.01) , C07D 235/06 (2006.01) | | Title | N3-alkylerede benzimidazolderivater som MEK-inhibitorer | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
